Ilyas K. Colombowala, MD, FACC, FHRS
Cardiac Electrophysiology · Houston, TX · colombowala.com

Condition

Brugada Syndrome

Sodium-channelopathy with coved ST elevation in the right precordial leads and risk of polymorphic VT/VF, often during sleep or fever. Diagnosis hinges on the type 1 pattern.

ECG features

  • Type 1 (diagnostic) — coved ST elevation ≥2 mm with a descending ST and inverted T in ≥1 right precordial lead (V1–V2)
  • Type 2 — saddleback ST elevation ≥0.5 mm with a positive/biphasic T; suggestive, not diagnostic
  • Higher right precordial lead placement (2nd–3rd intercostal space) increases sensitivity for the type 1 pattern
  • Pattern is dynamic — unmasked or accentuated by fever, sodium-channel blockers, vagal tone, and certain drugs
  • Conduction slowing — prolonged PR/QRS, fragmented QRS — and AF are common associations

Differential

  • RBBB (true terminal r' in V1 without the V1–V2 coved ST), athlete's heart, early repolarization
  • ARVC (epsilon waves, anterior TWI extending to V3+)
  • RVOT pathology, pectus excavatum, mediastinal/electrode misplacement
  • Hyperkalemia, acute ischemia/Prinzmetal, pericarditis, hypothermia (Osborn) — 'Brugada phenocopies'

Genetics and mechanism

Brugada syndrome is most often associated with loss-of-function in the cardiac sodium channel (SCN5A, ~20–30% of cases). The result is heterogeneous loss of the action-potential dome in the right ventricular outflow tract epicardium, creating transmural and epicardial dispersion of repolarization — the substrate for phase 2 reentry and polymorphic VT/VF. Events cluster at rest, during sleep, and with fever, when vagal tone is high and sodium current is further reduced.

ECG patterns

  • Type 1 (diagnostic)coved ST elevation ≥2 mm with a gradually descending ST segment into an inverted T wave, in ≥1 right precordial lead.
  • Type 2saddleback morphology; suggestive only. Pursue with higher leads and, if appropriate, provocation.
  • High right precordial leads (V1–V2 placed in the 2nd or 3rd intercostal space) markedly improve sensitivity.

The pattern is dynamic — it can be transiently present, so a single normal ECG does not exclude the diagnosis.

Provocation and unmasking

  • Fever — the most clinically important provoker; obtain an ECG in any suspected patient who is febrile.
  • Sodium-channel blocker challenge — IV ajmaline, procainamide, or flecainide to unmask type 1 in a patient with a non-diagnostic baseline and a compatible history/family history. Perform with monitoring and resuscitation readiness; a positive test converts type 2 to type 1.

Risk stratification

  • Highest risk: aborted cardiac arrest, or spontaneous type 1 with arrhythmic syncope
  • Intermediate: spontaneous type 1 without symptoms — individualized
  • Lower: drug-induced type 1 in an asymptomatic patient without family history
  • The role of EP study with programmed stimulation for risk stratification remains debated and is used selectively, not routinely

Management

  • ICD — the only therapy proven to prevent sudden death; indicated for cardiac-arrest survivors and high-risk symptomatic patients. The subcutaneous ICD is often attractive (young patients, no pacing need) — confirm S-ICD screening, since the Brugada ECG can challenge sensing.
  • Quinidine — reduces recurrent VF; used for electrical storm, as an adjunct, or when an ICD is declined/contraindicated.
  • Isoproterenol — acute therapy for electrical storm (augments calcium current, restores the epicardial dome).
  • Lifestyle: prompt fever treatment, avoid provoking drugs (brugadadrugs.org), moderate alcohol, avoid large nocturnal meals.
  • Family screening: clinical ± genetic cascade screening of first-degree relatives.

Last reviewed by Dr. Colombowala on May 27, 2026.

Clinical-reference content, not medical advice. This page is written for EP staff and does not create a doctor-patient relationship. It does not replace institutional policy, current device manuals, or attending direction during a case. See the full disclaimer.

© 2026 Ilyas K. Colombowala, MD. All rights reserved. Reproduction, redistribution, or republication of this content in any form without written permission is prohibited.

Source: